Pregnancy (Hoboken). 2026 Nov 14;2(6):e70506. doi: 10.1002/pmf2.70506. eCollection 2026 Nov.
ABSTRACT
INTRODUCTION: Patients with mechanical heart valves in pregnancy are at a substantially higher risk of adverse maternal and fetal outcomes. Management of patients with mechanical heart valves poses a unique challenge, and strategies for anticoagulation in these patients remain controversial. The goal of this project was to determine rates of adverse maternal and perinatal outcomes in patients with mechanical valves compared to those with bioprosthetic valves, and assess outcomes in patients with mechanical valves using low molecular weight heparin and warfarin.
METHODS: A retrospective query was performed using Epic Cosmos to evaluate pregnancies affected by mechanical and bioprosthetic heart valves between January 1, 2023 and January 1, 2026. Patient demographics and rates of adverse cardiac outcomes in the perinatal period, including heart failure, arrhythmia, and stroke, were assessed. The rate of anticoagulation with low molecular weight heparin and warfarin in patients with mechanical heart valves was evaluated, and cardiac and perinatal outcomes were determined and compared between groups. Rare outcomes were reported as <10 to protect patient privacy.
RESULTS: Baseline demographics between patients with mechanical and bioprosthetic heart valves were similar. Rates of heart failure (22.9%) and stroke (11.7%) were significantly higher in patients with mechanical compared to bioprosthetic heart valves, though the rates of maternal arrhythmia were similar between groups. Valve thrombosis was a rare outcome for patients with mechanical valves, with fewer than 10 events in the study sample. Perinatal outcomes including preterm and cesarean delivery were similar between groups.
CONCLUSION: In conclusion, mechanical heart valves are associated with high rates of heart failure and stroke in pregnancy. Rates of adverse events may be similar for patients using low molecular weight heparin compared to warfarin for anticoagulation in pregnancy.
PMID:43034628 | PMC:PMC13769046 | DOI:10.1002/pmf2.70506

